Day: July 2, 2024

MONTREAL, July 02, 2024 (GLOBE NEWSWIRE) — Bombardier expects its supply contracts to be maintained to the highest standards of quality and performance. The company remains actively engaged with Spirit as part of ordinary course of business under existing contracts. About Bombardier At Bombardier (BBD-B.TO), we design, build, modify and maintain the world’s best-performing aircraft for the world’s most discerning people and businesses, governments and militaries. That means not simply exceeding standards, but understanding customers well enough to anticipate their unspoken needs. For them, we are committed to pioneering the future of aviation—innovating to make flying more reliable, efficient and sustainable. And we are passionate about delivering unrivaled craftsmanship and care, giving our customers greater confidence and the...

TAMPA, Fla., July 02, 2024 (GLOBE NEWSWIRE) — Kforce Inc. (NYSE: KFRC), a provider of professional staffing services and solutions, expects to release second quarter results post-market on Monday, July 29, 2024, followed by a conference call at 5:00 pm ET to discuss the results. The dial-in number is (800) 715-9871 and the conference passcode is “Kforce.” A replay of the call will be available on our website at https://investor.kforce.com for one year after the call. About Kforce Inc. Kforce is a solutions firm specializing in technology, finance and accounting, and professional staffing services. Our KNOWLEDGEforce® empowers industry-leading companies to achieve their digital transformation goals. We curate teams of technical experts who build solutions custom-tailored to each client’s needs. These scalable, flexible outcomes...

MIAMI, July 02, 2024 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), will hold a conference call on Wednesday, August 7, 2024, at 8:00 a.m. ET to discuss its results for the second quarter ended June 30, 2024. AYR President & CEO David Goubert and CFO Brad Asher will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call. Date: Wednesday, August 7, 2024Time: 8:00 a.m. ETToll-free dial-in number: (844) 763-8274International dial-in number: (647) 484-8814Conference ID: 10190621Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=bRdrPVJ3 A telephonic replay of the conference call will also be available...

116 patients enrolled June represents a new record breaking month for patient enrollment TORONTO, July 02, 2024 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. Enrollment:Robust enrollment activity continuing throughout the first half of 2024:116 patients enrolled at end of June 2024Record monthly enrollment with nine patients enrolled in June Thirty-five patients enrolled in 2024 so far – represents the most robust enrollment rates since the start of the Tigris studyWith...

AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that Melissa Moore, Ph.D., Vice President, Clinical Research and Development, will give a presentation at 11:30 a.m. EDT at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer on July 8, 2024 in Newry, Maine. The presentation will report data from the ReSPECT-GBM and ReSPECT-LM clinical studies evaluating the Company’s lead radiotherapeutic, rhenium (186Re) obisbemeda, for the treatment of recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). Details of presentations:Title Targeted Radiolabeled Nanoliposomes...

VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) announces that Michael Luzich has retired from Amerigo’s board of directors effective June 30, 2024. Mr. Luzich joined the Amerigo board on May 12, 2020. Mr. Luzich is the founder of Luzich Partners LLC, a multi-strategy investment firm formed in 2013 and a significant shareholder of the Company. Mr. Luzich is stepping down from the Amerigo board of directors to devote more time to his other business endeavours. “I would like to extend our appreciation to Michael for having served as a director of the Company over the last four years and for his insights and contributions during this time,” stated Dr. Klaus Zeitler, Executive Chair of Amerigo. “We are sure Michael will continue adding to his...

Delivering the next step towards long-term global sustainability targets  Investment of approximately $150 million in the Alloa site over the next two years Perrysburg, Ohio, July 02, 2024 (GLOBE NEWSWIRE) —  O-I Glass, Inc. (“O-I Glass” or “O-I”) plans a major transformation of its Alloa, UK manufacturing plant into an even more technologically advanced facility with an expected significant reduction in CO2 emissions.   Over the next two years, the company plans to invest approximately $150 million in a series of upgrades to the site. The transformation includes a rebuild of one of its existing furnaces, featuring state-of-the art technology and improved sustainability performance through several planned measures including gas-oxy combustion and increased levels of renewable energy and recycled glass.  In addition, O-I...

Technical and Field Services to be deployed in Europe, Middle East and US for US DoD Programs PETAH TIKVA, Israel, July 02, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that Gilat’s wholly owned US-based subsidiary, DataPath Inc, received over $9 million in orders in support of the US Department of Defense and other agencies worldwide participating in Field Service and Technical Service Programs. DataPath is deploying technical services and field services in Europe, the Middle East, and the United States to support U.S. Defense end users’ critical connectivity requirements. These orders include both contract extensions and new contracts from various partners and agencies. “In addition to being a leading...

Featured the largest U.S. company IPO and switch Nasdaq IPO Pulse Index signals positive outlook for remainder of 2024 NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) announced today that in the first half of 2024, it welcomed 66 initial public offerings (IPOs), raising a total of $8.7 billion. A total of 53 operating companies and 13 SPACs listed on Nasdaq during the first six months of 2024, representing a 71% win rate of Nasdaq-eligible operating company IPOs in the U.S. market, and extending Nasdaq’s leadership to 42 consecutive quarters. In addition to the IPOs, 7 companies transferred their corporate listing to Nasdaq, including Science Applications International Corp (SAIC), the largest exchange transfer so far this year, representing $7.4 billion in market cap. “The first half of the year has been off to...